201 related articles for article (PubMed ID: 26357501)
21. Dual phase cone-beam computed tomography in detecting <3 cm hepatocellular carcinomas during transarterial chemoembolization.
Wang X; Yarmohammadi H; Cao G; Ji X; Hu J; Yarmohammadi H; Chen H; Zhu X; Yang R; Solomon SB
J Cancer Res Ther; 2017; 13(1):38-43. PubMed ID: 28508831
[TBL] [Abstract][Full Text] [Related]
22. Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival rates.
Takayasu K; Muramatsu Y; Maeda T; Iwata R; Furukawa H; Muramatsu Y; Moriyama N; Okusaka T; Okada S; Ueno H
AJR Am J Roentgenol; 2001 Mar; 176(3):681-8. PubMed ID: 11222205
[TBL] [Abstract][Full Text] [Related]
23. Transarterial chemoembolization with drug-eluting beads in hepatocellular carcinoma: usefulness of contrast saturation features on cone-beam computed tomography imaging for predicting short-term tumor response.
Suk Oh J; Jong Chun H; Gil Choi B; Giu Lee H
J Vasc Interv Radiol; 2013 Apr; 24(4):483-9. PubMed ID: 23452553
[TBL] [Abstract][Full Text] [Related]
24. Angio-Computed Tomograph-Guided Immediate Lipiodol Computed Tomograph for Diagnosis of Small Hepatocellular Carcinoma Lesions during Transarterial Chemoembolization.
Liu FY; Li X; Yuan HJ; Guan Y; Wang MQ
Chin Med J (Engl); 2018 Oct; 131(20):2410-2416. PubMed ID: 30334525
[TBL] [Abstract][Full Text] [Related]
25. Segmental transarterial chemoembolization with Lipiodol mixed with anticancer drugs for nonresectable hepatocellular carcinoma: follow-up CT and therapeutic results.
Nishimine K; Uchida H; Matsuo N; Sakaguchi H; Hirohashi S; Nishimura Y; Guo Q; Ohishi H; Nagano N; Yoshioka T
Cancer Chemother Pharmacol; 1994; 33 Suppl():S60-8. PubMed ID: 7511069
[TBL] [Abstract][Full Text] [Related]
26. Comparison of Image Quality and Diagnostic Performance of Cone-Beam CT during Drug-Eluting Embolic Transarterial Chemoembolization and Multidetector CT in the Detection of Hepatocellular Carcinoma.
Lucatelli P; Argirò R; Ginanni Corradini S; Saba L; Cirelli C; Fanelli F; Ricci C; Levi Sandri GB; Catalano C; Bezzi M
J Vasc Interv Radiol; 2017 Jul; 28(7):978-986. PubMed ID: 28495451
[TBL] [Abstract][Full Text] [Related]
27. The Role of Dual-Phase Cone-Beam CT in Predicting Short-Term Response after Transarterial Chemoembolization for Hepatocellular Carcinoma.
Müller K; Datta S; Gehrisch S; Ahmad M; Mohammed MA; Rosenberg J; Hwang GL; Louie JD; Sze DY; Kothary N
J Vasc Interv Radiol; 2017 Feb; 28(2):238-245. PubMed ID: 27914917
[TBL] [Abstract][Full Text] [Related]
28. Safety margins of hepatocellular carcinoma demonstrated by 3-dimensional fused images of computed tomographic hepatic arteriography/unenhanced computed tomography: prognostic significance in patients who underwent transcatheter arterial chemoembolization.
Tajima T; Nishie A; Asayama Y; Ishigami K; Ushijima Y; Kakihara D; Honda H
J Comput Assist Tomogr; 2010; 34(5):712-9. PubMed ID: 20861774
[TBL] [Abstract][Full Text] [Related]
29. Optimal measurement modality and method for evaluation of responses to transarterial chemoembolization of hepatocellular carcinoma based on enhancement criteria.
Shim JH; Han S; Shin YM; Yu E; Park W; Kim KM; Lim YS; Lee HC
J Vasc Interv Radiol; 2013 Mar; 24(3):316-25. PubMed ID: 23312990
[TBL] [Abstract][Full Text] [Related]
30. Hepatocellular carcinoma responding to superselective transarterial chemoembolization: an issue of nodule dimension?
Golfieri R; Renzulli M; Mosconi C; Forlani L; Giampalma E; Piscaglia F; Trevisani F; Bolondi L;
J Vasc Interv Radiol; 2013 Apr; 24(4):509-17. PubMed ID: 23428355
[TBL] [Abstract][Full Text] [Related]
31. Three-dimensional evaluation of lipiodol retention in HCC after chemoembolization: a quantitative comparison between CBCT and MDCT.
Wang Z; Lin M; Lesage D; Chen R; Chapiro J; Gu T; Tacher V; Duran R; Geschwind JF
Acad Radiol; 2014 Mar; 21(3):393-9. PubMed ID: 24507426
[TBL] [Abstract][Full Text] [Related]
32. Clinical evaluation of transcatheter arterial chemoembolization with 2-day-soluble gelatin sponge particles for hepatocellular carcinoma-comparison with insoluble gelatin sponge particles.
Kawai N; Sato M; Minamiguchi H; Ikoma A; Sanda H; Nakata K; Sato H; Sakaguchi H; Nakai M; Sonomura T
J Vasc Interv Radiol; 2013 Sep; 24(9):1383-90. PubMed ID: 23727419
[TBL] [Abstract][Full Text] [Related]
33. Radiological response predicts survival following transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma.
Kim DY; Ryu HJ; Choi JY; Park JY; Lee DY; Kim BK; Kim SU; Ahn SH; Chon CY; Han KH
Aliment Pharmacol Ther; 2012 Jun; 35(11):1343-50. PubMed ID: 22486716
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of metabolic characteristics and viability of lipiodolized hepatocellular carcinomas using 18F-FDG PET/CT.
Kim HO; Kim JS; Shin YM; Ryu JS; Lee YS; Lee SG
J Nucl Med; 2010 Dec; 51(12):1849-56. PubMed ID: 21098794
[TBL] [Abstract][Full Text] [Related]
35. Quantitative Automated Segmentation of Lipiodol Deposits on Cone-Beam CT Imaging Acquired during Transarterial Chemoembolization for Liver Tumors: A Deep Learning Approach.
Malpani R; Petty CW; Yang J; Bhatt N; Zeevi T; Chockalingam V; Raju R; Petukhova-Greenstein A; Santana JG; Schlachter TR; Madoff DC; Chapiro J; Duncan J; Lin M
J Vasc Interv Radiol; 2022 Mar; 33(3):324-332.e2. PubMed ID: 34923098
[TBL] [Abstract][Full Text] [Related]
36. Warming effect on miriplatin-lipiodol suspension as a chemotherapeutic agent for transarterial chemoembolization for hepatocellular carcinoma: preliminary clinical experience.
Kora S; Urakawa H; Mitsufuji T; Osame A; Higashihara H; Yoshimitsu K
Cardiovasc Intervent Radiol; 2013 Aug; 36(4):1023-9. PubMed ID: 23238851
[TBL] [Abstract][Full Text] [Related]
37. Long-term outcome of transcatheter subsegmental and segmental arterial chemoemobolization using lipiodol for hepatocellular carcinoma.
Takaki S; Sakaguchi H; Anai H; Tanaka T; Yamamoto K; Morimoto K; Nishiofuku H; Inoue M; Sueyoshi S; Nagata T; Hidaka T; Uchida H; Kichikawa K
Cardiovasc Intervent Radiol; 2012 Jun; 35(3):544-54. PubMed ID: 21739345
[TBL] [Abstract][Full Text] [Related]
38. Lipiodol trans-arterial chemoembolization of hepatocellular carcinoma with idarubicin: first experience.
Favelier S; Boulin M; Hamza S; Cercueil JP; Cherblanc V; Lepage C; Hillon P; Chauffert B; Krausé D; Guiu B
Cardiovasc Intervent Radiol; 2013 Aug; 36(4):1039-46. PubMed ID: 23224215
[TBL] [Abstract][Full Text] [Related]
39. Hug sign in intraprocedural cone-beam-CT to predict short-term response to combined treatment of hepatocellular carcinoma.
Iezzi R; Posa A; Valente I; Contegiacomo A; Zocco MA; Pompili M; Annicchiarico BE; Ponziani FR; Basso M; Goldberg SN; Giuliante F; Gasbarrini A; Sala E;
Radiol Med; 2024 May; 129(5):807-816. PubMed ID: 38512624
[TBL] [Abstract][Full Text] [Related]
40. Correlation of tumor response on computed tomography with pathological necrosis in hepatocellular carcinoma treated by chemoembolization before liver transplantation.
Dioguardi Burgio M; Ronot M; Bruno O; Francoz C; Paradis V; Castera L; Durand F; Soubrane O; Vilgrain V
Liver Transpl; 2016 Nov; 22(11):1491-1500. PubMed ID: 27543821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
